SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009577
Filing Date
2018-04-27
Accepted
2018-04-27 16:10:46
Documents
5
Period of Report
2018-06-22
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A omed-def14a_20180622.htm DEF 14A 1329559
2 GRAPHIC g2018042718160846823699.jpg GRAPHIC 84540
3 GRAPHIC g2018042718160850123700.jpg GRAPHIC 57992
4 GRAPHIC g2018042718160195723697.jpg GRAPHIC 3005
5 GRAPHIC g2018042718160845623698.jpg GRAPHIC 3005
  Complete submission text file 0001564590-18-009577.txt   1535774
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35993 | Film No.: 18783955
SIC: 2834 Pharmaceutical Preparations